Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. 1993

V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
Department of Cardiology, Université de Bordeaux II, Hôpital Saint-André, France.

BACKGROUND Thrombosis of the central veins is one of the most frequent complications of implanted venous access devices. Among the first cases occurring in our patients, most were associated with left-sided placement of the ports, with catheter tips lying against the external wall in the upper half of the superior vena cava. Some chest radiographs showed lateromediastinal opacities centered on the catheter tip, suggesting a vessel injury. This position allows a narrow contact between the catheter tip and the vessel wall, thus endothelial injuries might result from mechanical and chemical attack. METHODS To assess the role of catheter position, we reviewed the routine chest radiographs of 379 patients who received chemotherapy through venous access devices and were followed up at our department between December 1985 and December 1990. Four groups (upper left, upper right, lower left, and lower right) were defined according to the level of the catheter tip (innominate veins or upper half of the vena cava versus lower half of the vena cava or auricula) and to the side of port implantation. RESULTS Ten patients developed symptomatic venous thrombosis (superior vena cava in 9 patient, left subclavian vein in 1 patient). A strong correlation existed between catheter position and incidence of thrombosis: upper left, 8/28 (28.6%); upper right, 1/33 (3%); lower right, 1/68 (1.5%); and lower left, 0/250. Since 1988, we have insisted on replacement of malpositioned catheters, and we have observed fewer thromboses (2/191 versus 8/188). CONCLUSIONS The current study suggests that patients with left-sided ports and catheter tips lying in the upper part of the vena cava are at high risk for severe thrombotic complications.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002408 Catheters, Indwelling Catheters designed to be left within an organ or passage for an extended period of time. Implantable Catheters,In-Dwelling Catheters,Catheter, In-Dwelling,Catheter, Indwelling,Catheters, In-Dwelling,In Dwelling Catheters,In-Dwelling Catheter,Indwelling Catheter,Indwelling Catheters
D004868 Equipment Failure Failure of equipment to perform to standard. The failure may be due to defects or improper use. Defects, Equipment,Device Failure,Failure, Equipment,Malfunction, Equipment,Medical Device Failure,Misuse, Equipment,Device Failure, Medical,Device Failures, Medical,Failure, Medical Device,Failures, Medical Device,Defect, Equipment,Device Failures,Equipment Defect,Equipment Defects,Equipment Failures,Equipment Malfunction,Equipment Malfunctions,Equipment Misuse,Equipment Misuses,Failure, Device,Failures, Device,Failures, Equipment,Malfunctions, Equipment,Misuses, Equipment
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013479 Superior Vena Cava Syndrome A condition that occurs when the obstruction of the thin-walled SUPERIOR VENA CAVA interrupts blood flow from the head, upper extremities, and thorax to the RIGHT ATRIUM. Obstruction can be caused by NEOPLASMS; THROMBOSIS; ANEURYSM; or external compression. The syndrome is characterized by swelling and/or CYANOSIS of the face, neck, and upper arms which is called Pemberton's sign. Classification of SVC obstruction is often based on COLLATERAL CIRCULATION. Obstruction of the Superior Vena Cava,SVC Obstruction,SVC Syndrome,SVC Thrombosis,Superior Vena Cava Obstruction,Superior Vena Cava Thrombosis,Obstruction, SVC,SVC Obstructions,SVC Syndromes,SVC Thromboses,Syndrome, SVC,Thrombosis, SVC

Related Publications

V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
April 2012, Revista espanola de cardiologia (English ed.),
V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
December 2013, Revista clinica espanola,
V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
January 2021, Annals of cardiac anaesthesia,
V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
January 2012, Case reports in vascular medicine,
V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
March 2016, The journal of vascular access,
V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
January 2004, Journal of infusion nursing : the official publication of the Infusion Nurses Society,
V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
September 2013, Indian journal of nephrology,
V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
September 2022, The American journal of medicine,
V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
March 1990, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
V Puel, and M Caudry, and P Le Métayer, and J C Baste, and D Midy, and C Marsault, and H Demeaux, and J P Maire
February 2014, Vnitrni lekarstvi,
Copied contents to your clipboard!